Richard E.  Caruso net worth and biography

Richard Caruso Biography and Net Worth

Major Shareholder of Integra LifeSciences
Dr. Richard E. Caruso is the Founder and Chairman Emeritus at Integra Lifesciences Corp.

What is Richard E. Caruso's net worth?

The estimated net worth of Richard E. Caruso is at least $4.86 million as of June 18th, 2020. Dr. Caruso owns 163,668 shares of Integra LifeSciences stock worth more than $4,857,666 as of April 23rd. This net worth evaluation does not reflect any other investments that Dr. Caruso may own. Learn More about Richard E. Caruso's net worth.

How do I contact Richard E. Caruso?

The corporate mailing address for Dr. Caruso and other Integra LifeSciences executives is 311 ENTERPRISE DRIVE, PLAINSBORO NJ, 08536. Integra LifeSciences can also be reached via phone at (609) 275-0500 and via email at [email protected]. Learn More on Richard E. Caruso's contact information.

Has Richard E. Caruso been buying or selling shares of Integra LifeSciences?

Richard E. Caruso has not been actively trading shares of Integra LifeSciences during the past quarter. Most recently, Richard E. Caruso sold 600,000 shares of the business's stock in a transaction on Thursday, June 18th. The shares were sold at an average price of $48.47, for a transaction totalling $29,082,000.00. Following the completion of the sale, the insider now directly owns 163,668 shares of the company's stock, valued at $7,932,987.96. Learn More on Richard E. Caruso's trading history.

Who are Integra LifeSciences' active insiders?

Integra LifeSciences' insider roster includes Richard Caruso (Major Shareholder), Glenn Coleman (COO), Jan De Witte (CEO), Stuart Essig (Director), Lisa Evoli (EVP), Michael McBreen (EVP), Jeffrey Mosebrook (SVP), Raymond Murphy (Director), and Eric Schwartz (EVP). Learn More on Integra LifeSciences' active insiders.

Are insiders buying or selling shares of Integra LifeSciences?

In the last year, Integra LifeSciences insiders bought shares 1 times. They purchased a total of 7,792 shares worth more than $299,992.00. The most recent insider tranaction occured on June, 1st when CEO Witte Jan De bought 7,792 shares worth more than $299,992.00. Insiders at Integra LifeSciences own 3.1% of the company. Learn More about insider trades at Integra LifeSciences.

Information on this page was last updated on 6/1/2023.

Richard E. Caruso Insider Trading History at Integra LifeSciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/18/2020Sell600,000$48.47$29,082,000.00163,668View SEC Filing Icon  
12/19/2019Sell491,205$59.42$29,187,401.10134,134View SEC Filing Icon  
9/19/2019Sell520,000$60.97$31,704,400.00134,134View SEC Filing Icon  
8/22/2019Sell80,000$61.77$4,941,600.00134,134View SEC Filing Icon  
3/13/2019Sell30,128$56.06$1,688,975.68143,384View SEC Filing Icon  
10/17/2018Sell46,676$63.19$2,949,456.44134,134View SEC Filing Icon  
3/8/2018Sell32,880$53.68$1,764,998.40View SEC Filing Icon  
See Full Table

Richard E. Caruso Buying and Selling Activity at Integra LifeSciences

This chart shows Richard E Caruso's buying and selling at Integra LifeSciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Integra LifeSciences Company Overview

Integra LifeSciences logo
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Read More

Today's Range

Now: $29.62
Low: $28.97
High: $29.80

50 Day Range

MA: $36.55
Low: $28.68
High: $45.20

2 Week Range

Now: $29.62
Low: $27.85
High: $59.10

Volume

474,943 shs

Average Volume

684,853 shs

Market Capitalization

$2.33 billion

P/E Ratio

35.69

Dividend Yield

N/A

Beta

1.12